H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients.

Nature Communications
Kolja SchleichClemens A Schmitt

Abstract

Lesion-based targeting strategies underlie cancer precision medicine. However, biological principles - such as cellular senescence - remain difficult to implement in molecularly informed treatment decisions. Functional analyses in syngeneic mouse models and cross-species validation in patient datasets might uncover clinically relevant genetics of biological response programs. Here, we show that chemotherapy-exposed primary Eµ-myc transgenic lymphomas - with and without defined genetic lesions - recapitulate molecular signatures of patients with diffuse large B-cell lymphoma (DLBCL). Importantly, we interrogate the murine lymphoma capacity to senesce and its epigenetic control via the histone H3 lysine 9 (H3K9)-methyltransferase Suv(ar)39h1 and H3K9me3-active demethylases by loss- and gain-of-function genetics, and an unbiased clinical trial-like approach. A mouse-derived senescence-indicating gene signature, termed "SUVARness", as well as high-level H3K9me3 lymphoma expression, predict favorable DLBCL patient outcome. Our data support the use of functional genetics in transgenic mouse models to incorporate basic biology knowledge into cancer precision medicine in the clinic.

References

Jul 1, 1990·Statistics in Medicine·Y Hochberg, Y Benjamini
Sep 6, 2000·Nature Medicine·C A SchmittS W Lowe
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Jun 28, 2002·Cancer Cell·Clemens A SchmittScott W Lowe
Apr 3, 2003·Nature Reviews. Cancer·Clemens A Schmitt
Aug 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·George WrightLouis M Staudt
May 4, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P FeugierB Coiffier
Aug 5, 2005·Nature·Melanie BraigClemens A Schmitt
Jun 9, 2006·The New England Journal of Medicine·Michael HummelUNKNOWN Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe
Jun 9, 2006·The New England Journal of Medicine·Sandeep S DaveUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Jan 30, 2008·The Lancet Oncology·Michael PfreundschuhUNKNOWN German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
Nov 29, 2008·The New England Journal of Medicine·G LenzUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Jul 28, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christian GisselbrechtNorbert Schmitz
Oct 19, 2010·Biochimica Et Biophysica Acta·Radhika A Varier, H T Marc Timmers
Jul 29, 2011·Nature·Ryan D MorinMarco A Marra
Aug 2, 2011·Nature Genetics·Laura PasqualucciRiccardo Dalla-Favera
Feb 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jens G LohrTodd R Golub
Apr 5, 2012·Nature Reviews. Genetics·Eric L Greer, Yang Shi
Apr 5, 2012·Nature Reviews. Molecular Cell Biology·Susanne Marije Kooistra, Kristian Helin
Apr 19, 2012·PloS One·Michael J KlukScott J Rodig
Jan 8, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jenny ZhangSandeep S Dave
May 7, 2013·Cancer Research·William L Berry, Ralf Janknecht
May 21, 2013·Biochimica Et Biophysica Acta·Stefano AmenteBarbara Majello
Nov 16, 2013·Nature Reviews. Drug Discovery·Jonas W HøjfeldtKristian Helin
Jun 3, 2014·Nature Communications·Michael R GreenIsidro Sánchez-García
Jul 18, 2014·Nature Reviews. Cancer·Pedro A Pérez-ManceraMasashi Narita
Oct 29, 2014·Molecular Cancer Therapeutics·Rachel E RempelDaphne R Friedman
Mar 25, 2015·Trends in Immunology·Audrey Lasry, Yinon Ben-Neriah
Jun 25, 2015·Nature Reviews. Cancer·Norman E Sharpless, Charles J Sherr
Sep 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H TillyUNKNOWN ESMO Guidelines Committee

❮ Previous
Next ❯

Citations

Aug 31, 2021·Frontiers in Cell and Developmental Biology·Jing YangXing Zhang
Sep 14, 2021·Nature·Soyoung LeeClemens A Schmitt

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE98588

Methods Mentioned

BETA
xenograft
transgenic
PCR
dissection

Software Mentioned

Bioconductor
GSEA NES
SUVARness
R
GSEA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

[Rinshō ketsueki] The Japanese journal of clinical hematology
Ken Ohmachi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Kieron DunleavyWyndham H Wilson
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición
Mónica Madrigal-VelázquezHéctor Mayani
© 2021 Meta ULC. All rights reserved